SEC Tracker
Get the app

GT Biopharma GTBP

GT Biopharma registers 13.5M shares for sale

Securities offering

Form
424B3
Filed
Importance
Routine
  1. 13,502,835 shares of common stock registered
  2. Includes 6,716,931 shares from Series M conversion
  3. Includes 30,004 shares from Series L conversion
  4. Includes 6,996 Q2 dividend shares and 1,969 Q3 dividend shares

Written from the 424B3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when GT Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Biovie BIVI public float $8M, Dec 31, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  4. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
  5. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025